Impact of ATOrvastatin REload on the Prevention of Contrast-INduced Nephropathy in patients on Chronic Statin Therapy: A prospective randomized trial (ATORE-CIN)

计划入组 102 人

Multiple Intervention and AUdit in Renal Diseases to Optimize Care

计划入组 788 人 · 首次发布于 2007 年 11 月 30 日

COVID-19 Among Children With Chronic Renal Diseases in Qatar

计划入组 1,300 人 · 首次发布于 2022 年 3 月 11 日

NPY2r Agonist (cardio-renal-metabolic diseases)

FP-ALDH2 activator 1

TD-7601

RENAL DISEASE RESEARCH INSTITUTE, LLC

United States

River 3 Renal Corp.

United States

Southeast Renal Research Institute

United States

MultiOmic Health Partners with Serbia's BIO4 Campus to Develop AI-Driven Precision Medicine for Cardio-Renal-Metabolic Diseases

Dropshot Therapeutics Advances Renal Disease Program to Clinical Stage Using etherna's mRNA Platform

Alebund Pharmaceuticals Completes Series C Financing of RMB 550 Million